Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906642 · ClinicalTrials.gov registry record · NA
Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures
A NA study, sponsored by Next Science TM.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04906642 is a NA study that was terminated before completion, run by Next Science TM. The registered enrollment target is 17 participants.
The verdict
NCT04906642, a NA study, was terminated before completion, sponsored by Next Science TM.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, double-blinded clinical feasibility study of subjects that are being treated for Gustilo and Anderson Type II or IIIA or IIIB Tibial Fractures
Interventions
- OTHER Standard of Care
- DEVICE Next Science
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04906642
The ClinicalTrials.gov registry entry for NCT04906642 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Next Science TM, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04906642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04906642 about?
NCT04906642 is a clinical study titled "Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures". This is a prospective, randomized, controlled, double-blinded clinical feasibility study of subjects that are being treated for Gustilo and Anderson Type II or IIIA or IIIB Tibial Fractures
What is the current status of trial NCT04906642?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2021-05-04. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT04906642?
The interventions under investigation include: Standard of Care (OTHER), Next Science (DEVICE).
Who is sponsoring clinical trial NCT04906642?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.